• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Relationship between Very High Levels of Serum High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in a 20-Year Follow-Up Study of Japanese General Population.在一项对日本普通人群的20年随访研究中,血清高密度脂蛋白胆固醇极高水平与特定病因死亡率之间的关系。
J Atheroscler Thromb. 2016 Jul 1;23(7):800-9. doi: 10.5551/jat.33449. Epub 2016 Feb 26.
2
The inverse relationship between serum high-density lipoprotein cholesterol level and all-cause mortality in a 9.6-year follow-up study in the Japanese general population.在一项针对日本普通人群的9.6年随访研究中,血清高密度脂蛋白胆固醇水平与全因死亡率之间的负相关关系。
Atherosclerosis. 2006 Jan;184(1):143-50. doi: 10.1016/j.atherosclerosis.2005.03.042.
3
HDL cholesterol predicts coronary heart disease mortality in older persons.高密度脂蛋白胆固醇可预测老年人的冠心病死亡率。
JAMA. 1995 Aug 16;274(7):539-44.
4
A pooled analysis of the association of isolated low levels of high-density lipoprotein cholesterol with cardiovascular mortality in Japan.一项荟萃分析显示,日本孤立性低高密度脂蛋白胆固醇水平与心血管死亡率之间存在关联。
Eur J Epidemiol. 2017 Jul;32(7):547-557. doi: 10.1007/s10654-016-0203-1. Epub 2016 Oct 5.
5
Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men.孤立性低高密度脂蛋白胆固醇作为冠心病死亡的危险因素。对8000名男性进行的21年随访。
Arterioscler Thromb Vasc Biol. 1997 Jan;17(1):107-13. doi: 10.1161/01.atv.17.1.107.
6
[Apparent protective effect of high density lipoprotein against coronary heart disease in the elderly].[高密度脂蛋白对老年人冠心病的明显保护作用]
Zhonghua Yi Xue Za Zhi. 2003 May 25;83(10):827-31.
7
Associations between serum high-density lipoprotein cholesterol levels and cause-specific mortality in a general population of 345 000 men and women aged 20-79 years.在一个年龄在 20-79 岁的 345000 名男性和女性的普通人群中,血清高密度脂蛋白胆固醇水平与特定原因死亡率之间的关联。
Int J Epidemiol. 2023 Aug 2;52(4):1257-1267. doi: 10.1093/ije/dyad011.
8
Sex-dependent associations of plasma high-density lipoprotein cholesterol and mortality risk in healthy older men and women: two prospective cohort studies.健康老年男性和女性血浆高密度脂蛋白胆固醇与死亡率风险的性别相关性:两项前瞻性队列研究。
Geroscience. 2024 Apr;46(2):1461-1475. doi: 10.1007/s11357-023-00904-4. Epub 2023 Aug 23.
9
Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: The EPOCH-JAPAN study.极高水平高密度脂蛋白胆固醇与 9 项队列研究中 43407 名个体心血管死亡率的相关性荟萃分析:EPOCH-JAPAN 研究。
J Clin Lipidol. 2018 May-Jun;12(3):674-684.e5. doi: 10.1016/j.jacl.2018.01.014. Epub 2018 Feb 8.
10
High-density lipoprotein subclasses and risk of stroke and its subtypes in Japanese population: the Circulatory Risk in Communities Study.高密度脂蛋白亚类与日本人群中风及其亚型的风险:社区中的循环风险研究。
Stroke. 2013 Feb;44(2):327-33. doi: 10.1161/STROKEAHA.112.674812. Epub 2013 Jan 15.

引用本文的文献

1
High-density lipoproteins, Part 1. Epidemiology, antiatherogenic effects, and therapies designed to increase their serum levels.高密度脂蛋白,第1部分。流行病学、抗动脉粥样硬化作用以及旨在提高其血清水平的治疗方法。
Am J Prev Cardiol. 2025 Jul 21;23:101068. doi: 10.1016/j.ajpc.2025.101068. eCollection 2025 Sep.
2
Association between alcohol intake and death from cardiovascular diseases and its subtypes stratified by dyslipidemia in Japanese men: 20-years follow-up of NIPPON DATA90.日本男性饮酒与心血管疾病及其亚型死亡的相关性,以及按血脂异常分层:NIPPON DATA90 的 20 年随访。
Environ Health Prev Med. 2024;29:61. doi: 10.1265/ehpm.24-00164.
3
Association of serum Metrnl levels and high-density lipoprotein cholesterol in patients with type 2 diabetes mellitus: a cross-sectional study.2 型糖尿病患者血清 Metrnl 水平与高密度脂蛋白胆固醇的相关性:一项横断面研究。
PeerJ. 2024 Oct 14;12:e18264. doi: 10.7717/peerj.18264. eCollection 2024.
4
The relationship between serum HDL-cholesterol, cardiovascular disease and mortality in community-based people with type 2 diabetes: the Fremantle Diabetes Study phase 2.基于社区的 2 型糖尿病患者的血清高密度脂蛋白胆固醇、心血管疾病与死亡率之间的关系:弗里曼特尔糖尿病研究第二阶段。
Cardiovasc Diabetol. 2024 Oct 14;23(1):362. doi: 10.1186/s12933-024-02447-0.
5
Relationship Between Weight Loss, Changes in Serum hs-CRP Levels and apo A-1 Lipoprotein, and High-Density Lipoprotein-Cholesterol Ratios as Predictors for Improved Cardiovascular Risk Factors After Laparoscopic Sleeve Gastrectomy.腹腔镜袖状胃切除术对心血管危险因素改善的预测因素:体重减轻、血清 hs-CRP 水平和载脂蛋白 A-1 脂蛋白变化与高密度脂蛋白胆固醇比值的关系。
Obes Surg. 2024 Sep;34(9):3401-3411. doi: 10.1007/s11695-024-07441-9. Epub 2024 Aug 14.
6
Proteomic Analysis of Human Chylomicron Remnants Isolated by Apolipoprotein B-48 Immunoprecipitation.通过载脂蛋白B-48免疫沉淀法分离的人乳糜微粒残余物的蛋白质组学分析
J Atheroscler Thromb. 2025 Feb 1;32(2):226-238. doi: 10.5551/jat.64920. Epub 2024 Jul 31.
7
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022.日本动脉粥样硬化协会(JAS)2022年动脉粥样硬化性心血管疾病预防指南。
J Atheroscler Thromb. 2024 Jun 1;31(6):641-853. doi: 10.5551/jat.GL2022. Epub 2023 Dec 19.
8
High-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Risk Assessment: Exploring and Explaining the "U"-Shaped Curve.载脂蛋白 B 与非高密度脂蛋白胆固醇在动脉粥样硬化性心血管疾病风险评估中的应用:探索与解释“U”型曲线。
Curr Cardiol Rep. 2023 Dec;25(12):1725-1733. doi: 10.1007/s11886-023-01987-3. Epub 2023 Nov 16.
9
Association between extremely high-density lipoprotein cholesterol and adverse cardiovascular outcomes: a systematic review and meta-analysis.极高密度脂蛋白胆固醇与不良心血管结局之间的关联:一项系统评价和荟萃分析。
Front Cardiovasc Med. 2023 Jun 27;10:1201107. doi: 10.3389/fcvm.2023.1201107. eCollection 2023.
10
Does Elevated High-Density Lipoprotein Cholesterol Protect Against Cardiovascular Disease?高密度脂蛋白胆固醇升高能预防心血管疾病吗?
J Clin Endocrinol Metab. 2024 Jan 18;109(2):321-332. doi: 10.1210/clinem/dgad406.

本文引用的文献

1
Combined effect of blood pressure and total cholesterol levels on long-term risks of subtypes of cardiovascular death: Evidence for Cardiovascular Prevention from Observational Cohorts in Japan.血压和总胆固醇水平对心血管死亡亚型长期风险的联合影响:来自日本观察性队列的心血管预防证据
Hypertension. 2015 Mar;65(3):517-24. doi: 10.1161/HYPERTENSIONAHA.114.04639. Epub 2015 Jan 19.
2
Risk of hypercholesterolemia for cardiovascular disease and the population attributable fraction in a 24-year Japanese cohort study.一项为期24年的日本队列研究中高胆固醇血症导致心血管疾病的风险及人群归因分数
J Atheroscler Thromb. 2015;22(1):95-107. doi: 10.5551/jat.25908. Epub 2014 Sep 3.
3
Coronary heart disease risks associated with high levels of HDL cholesterol.与高水平高密度脂蛋白胆固醇相关的冠心病风险。
J Am Heart Assoc. 2014 Mar 13;3(2):e000519. doi: 10.1161/JAHA.113.000519.
4
Blood cholesterol level and risk of stroke in community-based or worksite cohort studies: a review of Japanese cohort studies in the past 20 years.基于社区或工作场所队列研究的血胆固醇水平与中风风险:对过去20年日本队列研究的综述
Keio J Med. 2012;61(3):79-88. doi: 10.2302/kjm.61.79.
5
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.胆固醇外排能力、高密度脂蛋白功能与动脉粥样硬化。
N Engl J Med. 2011 Jan 13;364(2):127-35. doi: 10.1056/NEJMoa1001689.
6
Population attributable fraction of smoking and metabolic syndrome on cardiovascular disease mortality in Japan: a 15-year follow up of NIPPON DATA90.日本人群归因分数研究:吸烟和代谢综合征与心血管疾病死亡率的 15 年随访结果——NIPPON DATA90 研究
BMC Public Health. 2010 Jun 3;10:306. doi: 10.1186/1471-2458-10-306.
7
Association of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the community.循环胆固醇酯转移蛋白活性与社区人群心血管疾病发病的相关性。
Circulation. 2009 Dec 15;120(24):2414-20. doi: 10.1161/CIRCULATIONAHA.109.872705.
8
HDL metabolism and CETP inhibition.高密度脂蛋白代谢与胆固醇酯转运蛋白抑制
Cardiol Rev. 2008 May-Jun;16(3):154-62. doi: 10.1097/CRD.0b013e31816a3b60.
9
Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.按年龄、性别和血压分层的血胆固醇与血管性死亡率:对61项前瞻性研究中55000例血管性死亡的个体数据进行的荟萃分析
Lancet. 2007 Dec 1;370(9602):1829-39. doi: 10.1016/S0140-6736(07)61778-4.
10
Effects of torcetrapib in patients at high risk for coronary events.托彻普对冠心病高危患者的影响。
N Engl J Med. 2007 Nov 22;357(21):2109-22. doi: 10.1056/NEJMoa0706628. Epub 2007 Nov 5.

在一项对日本普通人群的20年随访研究中,血清高密度脂蛋白胆固醇极高水平与特定病因死亡率之间的关系。

The Relationship between Very High Levels of Serum High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in a 20-Year Follow-Up Study of Japanese General Population.

作者信息

Hirata Aya, Okamura Tomonori, Sugiyama Daisuke, Kuwabara Kazuyo, Kadota Aya, Fujiyoshi Akira, Miura Katsuyuki, Okuda Nagako, Ohkubo Takayoshi, Okayama Akira, Ueshima Hirotsugu

机构信息

Department of Preventive Medicine and Public Health, Keio University School of Medicine.

出版信息

J Atheroscler Thromb. 2016 Jul 1;23(7):800-9. doi: 10.5551/jat.33449. Epub 2016 Feb 26.

DOI:10.5551/jat.33449
PMID:26923252
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7399265/
Abstract

AIMS

There is no community-based cohort study to examine the effect of very high level of high-density lipoprotein cholesterol (HDL-C) on coronary heart disease (CHD) and other cause-specific mortality. Therefore, we investigated the relationship between HDL-C including very high level and cause-specific mortality in a 20-year cohort study of the representative sample of Japanese.

METHODS

We followed 7,019 individuals from the Japanese general population (2,946 men and 4,073 women). We defined HDL-C levels as follow: low (HDL-C <1.04 mmol/L), reference (1.04-1.55 mmol/L), high (1.56-2.06 mmol/L), very high (≥2.07 mmol/L). The multivariate adjusted hazard ratio (HR) for all-cause or cause-specific mortality was calculated using a Cox proportional hazards model adjusted for other traditional risk factors.

RESULTS

During follow-up, we observed 1,598 deaths. No significant association was observed between HDL-C and all-cause mortality. Serum HDL-C also showed no association with stroke. In contrast, the risk for CHD among high HDL-C was lower than reference, HRs were 0.51 [95% confidence interval (CI): 0.21-1.23] in men, 0.33 (95% CI: 0.11-0.95) in women, and 0.41 (95% CI: 0.21-0.81) when men and women were combined. However, very high HDL-C did not show significant association with CHD and other cause-specific mortality.

CONCLUSIONS

HDL-C was not associated with all-cause and stroke mortality. In contrast, high serum HDL-C levels, at least up to 2.06 mmol/L, were protective against CHD, although further high levels were not. However, sample size of cause-specific death in very high HDL-C group was not enough even in this 20-year follow-up of 7,019 Japanese; larger cohort studies should be warranted.

摘要

目的

尚无基于社区的队列研究来检验极高水平的高密度脂蛋白胆固醇(HDL-C)对冠心病(CHD)及其他特定病因死亡率的影响。因此,我们在一项针对日本代表性样本的20年队列研究中,调查了包括极高水平在内的HDL-C与特定病因死亡率之间的关系。

方法

我们追踪了来自日本普通人群的7019人(2946名男性和4073名女性)。我们将HDL-C水平定义如下:低(HDL-C<1.04 mmol/L)、参照(1.04 - 1.55 mmol/L)、高(1.56 - 2.06 mmol/L)、极高(≥2.07 mmol/L)。使用针对其他传统风险因素进行调整的Cox比例风险模型计算全因或特定病因死亡率的多变量调整风险比(HR)。

结果

在随访期间,我们观察到1598例死亡。未观察到HDL-C与全因死亡率之间存在显著关联。血清HDL-C与中风也无关联。相比之下,HDL-C水平高的人群中冠心病风险低于参照组,男性的HR为0.51 [95%置信区间(CI):0.21 - 1.23],女性为0.33(95% CI:0.11 - 0.95),男女合并时为0.41(95% CI:0.21 - 0.81)。然而,极高HDL-C与冠心病及其他特定病因死亡率未显示出显著关联。

结论

HDL-C与全因及中风死亡率无关。相比之下,血清HDL-C高水平(至少高达2.06 mmol/L)对冠心病具有保护作用,尽管更高水平并非如此。然而,即使在对7019名日本人进行的这20年随访中,极高HDL-C组特定病因死亡的样本量也不足;需要开展更大规模的队列研究。